Struggling with a low libido? Daré Bioscience, a female-founded biotech company, has debuted a new prescription cream called ...
This article was reviewed by Felix Gussone, MD. Key Takeaways: Testosterone does more than drive puberty. It influences drive ...
On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...
INDIANAPOLIS (WISH) — This week, the Food and Drug Administration approved Addyi, the first medication for low libido in women younger than 65 years of age. Low libido affects 1 in 8 postmenopausal ...
If you pay even a little attention to the health and wellness space, you've probably noticed that testosterone is everywhere.
WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65. The ...
Testosterone is being hailed as the secret to better energy, mood, and sex drive. Here’s what experts say about when it actually does help—and when it doesn’t. Women naturally produce testosterone, a ...
Hosted on MSN
What ob-gyns think about the first libido-boosting pill approved for use after menopause
Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire disorder (HSDD)—had no dedicated treatment option available to them. But ...
Feeling like your libido has gone on holiday? Struggling with wanting to want but really just wanting to Netflix and, well, watch Netflix? Spending time wondering if you are broken? Or feeling shame ...
The drug, Addyi, was cleared a decade ago to treat low sex drive in women before menopause. The new FDA action allows treatment through age 65. The FDA has approved Addyi (flibanserin), a nonhormonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results